Brief: Agile Therapeutics Received Nasdaq Notice Of Delisting Or Failure To Satisfy A Continued Listing Rule Or Standard
19/08/2022 21:43
Aug 19 (Reuters) - Agile Therapeutics Inc AGRX.O :
* AGILE THERAPEUTICS INC - ON AUGUST 15, 2022 RECEIVED
NOTICE OF
DELISTING OR FAILURE TO SATISFY A CONTINUED LISTING RULE OR
STANDARD FROM NASDAQ
Source text for Eikon: [https://bit.ly/3Adm9SN]
Further company coverage: AGRX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Agile Therapeutics
See all newsBrief: Agile Therapeutics Inc. Announces Definitive Merger Agreement With Insud Pharma, S.L.
Agile Therapeutics Inc expected to post a loss of 92 cents a share - Earnings Preview
Brief: Agile Therapeutics Announces Delisting From Nasdaq
Agile Therapeutics Inc expected to post a loss of 54 cents a share - Earnings Preview
Brief: Agile Therapeutics Completes Pay-Off Of Debt